Is Schimke Immuno-Osseous Dysplasia hereditary?

Schimke immuno-osseous dysplasia (SIOD) is a hereditary genetic condition caused by mutations in the SMARCAL1 gene. It follows an autosomal recessive inheritance pattern, meaning an individual must inherit two copies of the mutated gene—one from each parent—to manifest the disease.

Is Schimke immuno-osseous dysplasia hereditary?

Yes, Schimke immuno-osseous dysplasia is a hereditary condition. Because it is autosomal recessive, parents of an affected child are typically asymptomatic carriers, each carrying one mutated copy of the SMARCAL1 gene. In such cases, there is a 25% chance for each pregnancy to result in a child affected by Schimke immuno-osseous dysplasia.

Are de novo mutations common in this condition?

While most cases of Schimke immuno-osseous dysplasia are inherited from carrier parents, de novo (spontaneous) mutations can occur. However, these are less common than familial inheritance. In cases where only one parent carries the mutation, it is crucial to investigate whether a de novo mutation occurred in the other allele during germ cell development.

How is genetic testing utilized for this condition?

Genetic testing for Schimke immuno-osseous dysplasia is performed via molecular analysis of the SMARCAL1 gene. Clinical geneticists recommend testing when a patient presents with the hallmark clinical triad of spondyloepiphyseal dysplasia, T-cell immunodeficiency, and progressive renal failure. Key diagnostic facts include:

• Inheritance: Autosomal recessive.


• Gene: SMARCAL1 (located on chromosome 2q35).


• Carrier Risk: Siblings of an affected individual have a 66% chance of being carriers.


• Prenatal Options: Couples with a known family history may pursue prenatal diagnosis via chorionic villus sampling (CVS) or amniocentesis.

What is the role of genetic counseling?

Genetic counseling is essential for families navigating a diagnosis of Schimke immuno-osseous dysplasia. Counselors provide clarity on recurrence risks, facilitate carrier testing for extended family members, and explain reproductive options such as preimplantation genetic testing (PGT) for those planning future pregnancies. Currently, four individuals with Schimke immuno-osseous dysplasia have joined the DiseaseMaps.org community, highlighting the importance of specialized support networks for rare disease families.

Next steps

• Consult with a board-certified clinical geneticist to confirm the diagnosis through molecular testing.


• Request a referral to a genetic counselor to discuss family planning and recurrence risks.


• Connect with the DiseaseMaps.org community to share experiences with other families affected by Schimke immuno-osseous dysplasia.

Medical disclaimer: This information is for educational purposes only and should not replace professional medical advice, diagnosis, or treatment.

References

• NIH Genetic and Rare Diseases Information Center (GARD): Schimke immuno-osseous dysplasia.


• Online Mendelian Inheritance in Man (OMIM): #242900 - Schimke immuno-osseous dysplasia.


• Orphanet: Rare disease database entry for Schimke immuno-osseous dysplasia (ORPHA:3146).